Loading
Life sciences · Journal article
International Journal of Biological Macromolecules · October 1, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Gene therapy and RNA-based therapeutics are increasingly limited by the challenge of delivering fragile, anionic nucleic acids to the correct intracellular compartment. Zein, the principal maize prolamin, has attracted interest as a biodegradable, self-assembling carrier that can protect cargo and be combined with polymeric, lipidic, targeted and biomimetic components. This review critically evaluates zein-based systems for plasmid DNA, siRNA, antisense oligonucleotides and related nucleic-acid cargos. Native zein is best regarded as a protective and sustained-release matrix rather than a stand-alone high-efficiency transfection vector. In contrast, hybrid systems can add nucleic-acid condensation, colloidal stabilization, targeting and intracellular-trafficking functions through components such as chitosan, polyethylenimine, dendritic poly(l-lysine), lipids and targeting ligands. Direct evidence of endosomal escape remains limited, with only one reviewed study providing imaging evidence consistent with improved lysosomal escape. Cargo-specific evidence is strongest for plasmid DNA, with functional proof-of-concept also reported for selected siRNA and antisense oligonucleotide systems, whereas robust mRNA translation and CRISPR genome editing have not yet been demonstrated with zein-based carriers. The translational rationale for zein lies not in superior intrinsic transfection efficiency, but in route-specific protection, sustained release, hydrophobic drug co-loading and use as a biodegradable scaffold within multifunctional hybrids. Zein-based gene delivery remains preclinical and requires stronger mechanistic, cargo-specific and route-specific validation.